|
|
Volumn 6, Issue 8, 2016, Pages OF7-
|
|
First-Line Atezolizumab Effective in Bladder Cancer
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ATEZOLIZUMAB;
MONOCLONAL ANTIBODY;
HUMAN;
PHASE 3 CLINICAL TRIAL (TOPIC);
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
URINARY BLADDER NEOPLASMS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS, PHASE III AS TOPIC;
HUMANS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
URINARY BLADDER NEOPLASMS;
|
|
EID: 85018514938
PISSN: None
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-NB2016-076 Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (0)
|